NextCure, Inc. NXTC
5.08
(0.20)
(3.79%)
as of 25 Sep
- Market cap
- $25.4M
- P/E
- 0.0×
Follow NXTC
Insider Buys
alert about insiders buying in the last 12 month
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
— | — | — | — |
EV/Sales |
— | — | — | — | |
EV/FCF |
— | — | — | — | |
Quick Ratio |
2.65 | 3.96 | 4.32 | 3.13 | |
Current Ratio |
2.97 | 4.14 | 4.61 | 3.47 | |
Net Debt/EBITDA |
3.44 | 4.43 | 3.01 | 1.35 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.73 | 0.81 | 1.36 | 0.65 | |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | 0.00 | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow Yield |
— | — | — | — | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(2.34) | (2.69) | (2.55) | (1.83) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
(2.34) | (2.69) | (2.55) | (1.83) | |
Cash per Share |
10.88 | 14.71 | 5.68 | 3.78 | |
Shareholders Equity per Share |
8.84 | 12.29 | 5.10 | 2.29 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
8.84 | 12.29 | 5.10 | 2.29 | |
Free Cash Flow |
(6.27) | (7.64) | (13.36) | (9.71) | |
Working Capital |
21.65 | 33.18 | 24.85 | 15.84 | |
Net Current Asset Value |
16.67 | 28.51 | 20.48 | 11.78 | |
EV/EBIT |
— | — | — | — | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% | |
| Other line items | |||||
Average Payables |
3.00 | 3.68 | 2.90 | 2.56 | |
Average Assets |
64.98 | 65.52 | 52.56 | 35.15 | |
Average Common Equity |
49.62 | 50.21 | 41.29 | 21.90 |
Columns are period end dates